ORENITRAM, created in 2013 (United States), from 16 sister brands and 2214 competing brands. ORENITRAM is a brand of United Therapeutics Co., listed on the stock exchange of New York. ORENITRAM belongs to the Biotechnology business sector.
Investment simulator :
Portfolio valuation
United Therapeutics Co.
(ORENITRAM)
over 5 years*
USD 549.18